VYOME HOLDINGS, INC. Restructuring Charges
VYOME HOLDINGS, INC. (HIND) reported Restructuring Charges of $0 for the 3-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2021-03-12
- VYOME HOLDINGS, INC. restructuring charges for the quarter ending 2019-12-31 was $0.00.
- VYOME HOLDINGS, INC. restructuring charges for the quarter ending 2019-09-30 was $0.00.
- VYOME HOLDINGS, INC. restructuring charges for the quarter ending 2019-06-30 was $1.10M.
- VYOME HOLDINGS, INC. restructuring charges for fiscal 2019 was $1.10M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $1.10M derived: sum of 3 quarters · filed 2021-03-12 | $1.10M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $0.00 10-K · filed 2020-02-27 | $1.10M derived: sum of 2 quarters · filed 2021-03-12 | $1.10M 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $1.10M 10-K · filed 2021-03-12 | $1.10M 10-Q · filed 2019-07-24 | $1.10M 10-Q · filed 2019-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |